For Many Biological Drugs, 'On The Market' Doesn't Mean Safe, Utrecht University Study
WASHINGTON (Reuters) - About a quarter of biological medicines approved in the United States and Europe since 1995 have triggered safety warnings in the years after entering the market, Dutch researchers said on Tuesday.